Esra Karakus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Esra Karakus has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Dilek Sahin
Department of Obstetrics and Gynecology, Turkish Ministry of Health, Ankara Bilkent City Hospital, Ankara, Turkey
3 shared publications- Ali Furkan Yahsi
Department of Pathology Turkish Ministry of Health, Ankara Bilkent City Hospital Ankara Turkey
2 shared publications - Arzu Meltem Demir
Department of Pediatric Gastroenterology Ankara University Faculty of Medicine Ankara Turkey
2 shared publications - Ayse Selcen Oguz Erdogan
Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
2 shared publications - Aytaç Yaman
Department of Pediatric Gastroenterology, Ministry of Health, Ankara City Hospital, Ankara, Turkey
2 shared publications - Burcu Berberoğlu Ateş
Department of Pediatric Gastroenterology, Ministry of Health, Ankara City Hospital, Ankara, Turkey
2 shared publications
Latest Publications
- 20 August 2026
- Published by SAGE Publications in Pediatric and Developmental Pathology
Fetal Vascular Malperfusion as a Key Association of Dysmorphic Chorionic Villi in the Third Trimester
Objective: Dysmorphic chorionic villi (DCV) are histopathological findings typically associated with chromosomal abnormalities in early pregnancy loss. This study aimed to evaluate the clinical and pathological significance of DCV across all trimesters, particularly investigating their association with fetal vascular malperfusion (FVM) and adverse pregnancy outcomes in late gestation. Methods: We retrospectively analyzed 100 placental cases with DCV diagnosed between June 2024 and July 2025. Cases were classified by trimester and assessed for maternal characteristics, fetal findings, and placental pathologies using standardized histomorphological criteria. Results: DCV were identified across all trimesters, with highest prevalence in the second trimester (57%). FVM was significantly more common in third-trimester placentas (72.4%) compared to first (7.1%) and second (17.5%) trimesters ( P < .001). Adverse fetal outcomes included medical termination (30%) and intrauterine fetal demise (25%), both confined to early trimesters. Chromosomal abnormalities were identified in 19% of cases, with trisomy 21 being most frequent (13%). Conclusion: DCV are not exclusive to early pregnancy loss but persist as clinically significant findings throughout gestation. The strong association between third-trimester DCV and FVM suggests these lesions may serve as prognostic histological markers for compromised fetoplacental perfusion. These findings support the need for standardized DCV criteria in placental classification systems and highlight the importance of genetic counseling when DCV are identified.
- 20 August 2026
- Published by SAGE Publications in Pediatric and Developmental Pathology
Fetal Vascular Malperfusion as a Key Association of Dysmorphic Chorionic Villi in the Third Trimester
Objective: Dysmorphic chorionic villi (DCV) are histopathological findings typically associated with chromosomal abnormalities in early pregnancy loss. This study aimed to evaluate the clinical and pathological significance of DCV across all trimesters, particularly investigating their association with fetal vascular malperfusion (FVM) and adverse pregnancy outcomes in late gestation. Methods: We retrospectively analyzed 100 placental cases with DCV diagnosed between June 2024 and July 2025. Cases were classified by trimester and assessed for maternal characteristics, fetal findings, and placental pathologies using standardized histomorphological criteria. Results: DCV were identified across all trimesters, with highest prevalence in the second trimester (57%). FVM was significantly more common in third-trimester placentas (72.4%) compared to first (7.1%) and second (17.5%) trimesters ( P < .001). Adverse fetal outcomes included medical termination (30%) and intrauterine fetal demise (25%), both confined to early trimesters. Chromosomal abnormalities were identified in 19% of cases, with trisomy 21 being most frequent (13%). Conclusion: DCV are not exclusive to early pregnancy loss but persist as clinically significant findings throughout gestation. The strong association between third-trimester DCV and FVM suggests these lesions may serve as prognostic histological markers for compromised fetoplacental perfusion. These findings support the need for standardized DCV criteria in placental classification systems and highlight the importance of genetic counseling when DCV are identified.
- 25 July 2026
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 96 (1) , e70301
First‐Trimester Maternal CALLY Index Is Associated With Fetal Growth Restriction
Background: Fetal growth restriction (FGR) is a major cause of perinatal morbidity and is frequently associated with placental malperfusion related to inflammatory and immune dysregulation. This study evaluated whether the first‐trimester maternal C‐reactive protein–albumin–lymphocyte (CALLY) index, a composite marker reflecting systemic inflammation, nutritional status, and immune competence, is associated with subsequent FGR. Methods: This retrospective case‐control study included 105 singleton pregnancies (69 FGR cases and 36 controls) at a tertiary center. FGR was diagnosed according to Delphi consensus criteria. The first‐trimester CALLY index was calculated as (albumin × lymphocyte count) / CRP. Placental histopathology was evaluated according to the Amsterdam Placental Workshop Group criteria. Group comparisons were performed using the Mann–Whitney U test and chi‐square or Fisher's exact test, and diagnostic performance was assessed using receiver operating characteristic (ROC) analysis. Results: The CALLY index was significantly lower in the FGR group compared with controls (0.065 vs 0.170, p < 0.001). FGR cases also had lower birthweight (1910 vs 3120 g, p < 0.001) and placental weight (344.5 vs 585 g, p < 0.001). Maternal vascular malperfusion (MVM) was more frequent in the FGR group (39.1% vs 13.9%, p = 0.015), while fetal vascular malperfusion (FVM) showed borderline significance (63.8% vs 41.7%, p = 0.050). ROC analysis demonstrated modest discriminatory ability for identifying FGR (AUC = 0.739, 95% CI: 0.652–0.826). A CALLY threshold ≤0.1265 yielded 75.4% sensitivity and 66.7% specificity. After adjustment for maternal age, low CALLY remained significantly associated with FGR (adjusted OR: 6.118, 95% CI: 2.529–14.799, p < 0.001). Early‐onset FGR cases (≤34 weeks) showed the lowest CALLY values (0.051). Additional ROC analyses for placental malperfusion endpoints showed limited discriminatory ability (AUCs: 0.592–0.636), indicating that CALLY is not a reliable standalone predictor of placental pathology. Conclusions: A low first‐trimester maternal CALLY index is associated with subsequent FGR. Its modest discriminatory ability for FGR (AUC = 0.739) suggests it may serve as a complementary tool in multi‐parameter risk assessment, particularly when integrated with clinical and sonographic findings. However, the limited performance for placental malperfusion endpoints indicates that CALLY should not be used as a standalone test for predicting placental pathology. Further prospective studies are needed to define its clinical role.
- 25 July 2026
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 96 (1) , e70301
First‐Trimester Maternal CALLY Index Is Associated With Fetal Growth Restriction
Background: Fetal growth restriction (FGR) is a major cause of perinatal morbidity and is frequently associated with placental malperfusion related to inflammatory and immune dysregulation. This study evaluated whether the first‐trimester maternal C‐reactive protein–albumin–lymphocyte (CALLY) index, a composite marker reflecting systemic inflammation, nutritional status, and immune competence, is associated with subsequent FGR. Methods: This retrospective case‐control study included 105 singleton pregnancies (69 FGR cases and 36 controls) at a tertiary center. FGR was diagnosed according to Delphi consensus criteria. The first‐trimester CALLY index was calculated as (albumin × lymphocyte count) / CRP. Placental histopathology was evaluated according to the Amsterdam Placental Workshop Group criteria. Group comparisons were performed using the Mann–Whitney U test and chi‐square or Fisher's exact test, and diagnostic performance was assessed using receiver operating characteristic (ROC) analysis. Results: The CALLY index was significantly lower in the FGR group compared with controls (0.065 vs 0.170, p < 0.001). FGR cases also had lower birthweight (1910 vs 3120 g, p < 0.001) and placental weight (344.5 vs 585 g, p < 0.001). Maternal vascular malperfusion (MVM) was more frequent in the FGR group (39.1% vs 13.9%, p = 0.015), while fetal vascular malperfusion (FVM) showed borderline significance (63.8% vs 41.7%, p = 0.050). ROC analysis demonstrated modest discriminatory ability for identifying FGR (AUC = 0.739, 95% CI: 0.652–0.826). A CALLY threshold ≤0.1265 yielded 75.4% sensitivity and 66.7% specificity. After adjustment for maternal age, low CALLY remained significantly associated with FGR (adjusted OR: 6.118, 95% CI: 2.529–14.799, p < 0.001). Early‐onset FGR cases (≤34 weeks) showed the lowest CALLY values (0.051). Additional ROC analyses for placental malperfusion endpoints showed limited discriminatory ability (AUCs: 0.592–0.636), indicating that CALLY is not a reliable standalone predictor of placental pathology. Conclusions: A low first‐trimester maternal CALLY index is associated with subsequent FGR. Its modest discriminatory ability for FGR (AUC = 0.739) suggests it may serve as a complementary tool in multi‐parameter risk assessment, particularly when integrated with clinical and sonographic findings. However, the limited performance for placental malperfusion endpoints indicates that CALLY should not be used as a standalone test for predicting placental pathology. Further prospective studies are needed to define its clinical role.
- 21 July 2026
- Published by SAGE Publications in Pediatric and Developmental Pathology
Association of First-Trimester Pan-Immune-Inflammation Value with Chronic Histiocytic Intervillositis and Villitis of Unknown Etiology
Background: Chronic histiocytic intervillositis (CHI) and villitis of unknown etiology (VUE) are immune-mediated placental disorders leading to adverse pregnancy outcomes. This study investigated whether first-trimester pan-immune-inflammation value (PIV), a novel systemic inflammation marker, is associated with these conditions. Methods: This retrospective case-control study (October 2022-August 2025) included 163 placentas (25 controls, 63 CHI, 75 VUE). First-trimester complete blood counts (P = .048). Across groups, PIV was highest in CHI (661.6), intermediate in VUE (446.4), and lowest in controls ( P < .001). CHI showed the worst perinatal outcomes: lowest gestational age (30.5 weeks), birth weight, and Apgar scores, and highest intrauterine fetal death (41.3%). After multivariable adjustment, first-trimester PIV remained independently associated with CHI (aOR 1.87, 95% CI 1.19-4.27, P = .005) but not with VUE (aOR 0.74, P = 0.103). Discriminatory performance was modest for CHI (AUC 0.677) and poor for VUE (AUC 0.434). Conclusion: Elevated first-trimester PIV is independently associated with CHI but not VUE, suggesting that systemic maternal inflammation may be detectable early in gestation, particularly in more severe placental immune pathology. PIV is not a standalone diagnostic test but may contribute to risk assessment when combined with clinical findings.
- 21 July 2026
- Published by SAGE Publications in Pediatric and Developmental Pathology
Association of First-Trimester Pan-Immune-Inflammation Value with Chronic Histiocytic Intervillositis and Villitis of Unknown Etiology
Background: Chronic histiocytic intervillositis (CHI) and villitis of unknown etiology (VUE) are immune-mediated placental disorders leading to adverse pregnancy outcomes. This study investigated whether first-trimester pan-immune-inflammation value (PIV), a novel systemic inflammation marker, is associated with these conditions. Methods: This retrospective case-control study (October 2022-August 2025) included 163 placentas (25 controls, 63 CHI, 75 VUE). First-trimester complete blood counts (P = .048). Across groups, PIV was highest in CHI (661.6), intermediate in VUE (446.4), and lowest in controls ( P < .001). CHI showed the worst perinatal outcomes: lowest gestational age (30.5 weeks), birth weight, and Apgar scores, and highest intrauterine fetal death (41.3%). After multivariable adjustment, first-trimester PIV remained independently associated with CHI (aOR 1.87, 95% CI 1.19-4.27, P = .005) but not with VUE (aOR 0.74, P = 0.103). Discriminatory performance was modest for CHI (AUC 0.677) and poor for VUE (AUC 0.434). Conclusion: Elevated first-trimester PIV is independently associated with CHI but not VUE, suggesting that systemic maternal inflammation may be detectable early in gestation, particularly in more severe placental immune pathology. PIV is not a standalone diagnostic test but may contribute to risk assessment when combined with clinical findings.
- 12 June 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (1) , 466-477
Integration of two‐dimensional microvascular flow imaging and ultrasound scoring for prediction of placenta accreta spectrum: A prospective study
Objective: This study evaluates the diagnostic performance of two‐dimensional (2D) microvascular flow imaging combined with standardized ultrasound markers for predicting placenta accreta spectrum disorders in pregnancies complicated by placenta previa or low‐lying placenta. Methods: This prospective observational study included 61 women with placenta previa or low‐lying placenta who underwent cesarean delivery between 32 and 38 weeks of gestation. All participants underwent standardized 2D microvascular flow imaging using the Samsung Hera W10 Elite system. The microvascular vascularization index was quantified as the percentage ratio of color‐coded vascular pixels within a defined placental region of interest. Conventional Doppler indices and standardized ultrasound markers associated with placenta accreta spectrum were recorded. Placental invasion was confirmed histopathologically in 23 patients. Statistical analyses included Mann–Whitney U ‐testing, receiver operating characteristic (ROC) analysis, 95% confidence interval estimation, pairwise ROC comparison using the DeLong method, and exploratory internally validated machine‐learning classification models. To avoid conceptual overlap and double counting, the total placenta accreta spectrum (PAS)score was excluded from the corrected machine‐learning models. Intraobserver reproducibility of repeated MVI measurements was assessed using the intraclass correlation coefficient. Results: The vascularization index was significantly higher in PAS cases than controls (47.65 ± 9.35 vs. 26.58 ± 8.93, P < 0.001). Conventional Doppler parameters did not differ significantly between groups. ROC analysis identified the vascularization index as the strongest single quantitative predictor of PAS, with an AUC of 0.985, sensitivity of 95.7%, and specificity of 97.4% at a cut‐off value of 37.11. The corrected Placental Invasion Risk Score, calculated without the total PAS score, showed excellent diagnostic performance, with an AUC of 0.998. Exploratory machine‐learning models excluding the total PAS score demonstrated improved discrimination after inclusion of the vascularization index, with logistic regression achieving an AUC of 0.990. Intraobserver reproducibility of repeated MVI measurements was excellent, with an intraclass correlation coefficient (ICC) of 0.977. For prediction of cesarean hysterectomy, the vascularization index also demonstrated excellent discriminatory performance at an optimal cut‐off value of ≥53.51. Conclusion: The 2D MV‐Flow vascularization index is a strong quantitative biomarker for predicting PAS in pregnancies complicated by placenta previa or low‐lying placenta. When combined with individual ultrasound markers, but not redundantly with the total PAS score, it may improve antenatal risk stratification and preoperative planning. However, the exploratory machine‐learning findings require external validation in larger multicenter cohorts.
- 12 June 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (1) , 466-477
Integration of two‐dimensional microvascular flow imaging and ultrasound scoring for prediction of placenta accreta spectrum: A prospective study
Objective: This study evaluates the diagnostic performance of two‐dimensional (2D) microvascular flow imaging combined with standardized ultrasound markers for predicting placenta accreta spectrum disorders in pregnancies complicated by placenta previa or low‐lying placenta. Methods: This prospective observational study included 61 women with placenta previa or low‐lying placenta who underwent cesarean delivery between 32 and 38 weeks of gestation. All participants underwent standardized 2D microvascular flow imaging using the Samsung Hera W10 Elite system. The microvascular vascularization index was quantified as the percentage ratio of color‐coded vascular pixels within a defined placental region of interest. Conventional Doppler indices and standardized ultrasound markers associated with placenta accreta spectrum were recorded. Placental invasion was confirmed histopathologically in 23 patients. Statistical analyses included Mann–Whitney U ‐testing, receiver operating characteristic (ROC) analysis, 95% confidence interval estimation, pairwise ROC comparison using the DeLong method, and exploratory internally validated machine‐learning classification models. To avoid conceptual overlap and double counting, the total placenta accreta spectrum (PAS)score was excluded from the corrected machine‐learning models. Intraobserver reproducibility of repeated MVI measurements was assessed using the intraclass correlation coefficient. Results: The vascularization index was significantly higher in PAS cases than controls (47.65 ± 9.35 vs. 26.58 ± 8.93, P < 0.001). Conventional Doppler parameters did not differ significantly between groups. ROC analysis identified the vascularization index as the strongest single quantitative predictor of PAS, with an AUC of 0.985, sensitivity of 95.7%, and specificity of 97.4% at a cut‐off value of 37.11. The corrected Placental Invasion Risk Score, calculated without the total PAS score, showed excellent diagnostic performance, with an AUC of 0.998. Exploratory machine‐learning models excluding the total PAS score demonstrated improved discrimination after inclusion of the vascularization index, with logistic regression achieving an AUC of 0.990. Intraobserver reproducibility of repeated MVI measurements was excellent, with an intraclass correlation coefficient (ICC) of 0.977. For prediction of cesarean hysterectomy, the vascularization index also demonstrated excellent discriminatory performance at an optimal cut‐off value of ≥53.51. Conclusion: The 2D MV‐Flow vascularization index is a strong quantitative biomarker for predicting PAS in pregnancies complicated by placenta previa or low‐lying placenta. When combined with individual ultrasound markers, but not redundantly with the total PAS score, it may improve antenatal risk stratification and preoperative planning. However, the exploratory machine‐learning findings require external validation in larger multicenter cohorts.
- 4 March 2026
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (3) , 246-253
Clinical Characteristics and Treatment Outcomes of Pediatric Pancreatic Solid Pseudopapillary Tumors: A Single-Center Experience
Objective: This study aimed to evaluate clinical characteristics, surgical management approaches, and long-term outcomes of pediatric patients with histopathologically-confirmed pancreatic solid pseudopapillary neoplasm (SPN) at a single tertiary center over 10 years. Methods: A retrospective review was conducted of 16 pediatric patients with pancreatic SPN who were treated at the hospital between 2015 and 2025. Data on demographics, clinical presentation, imaging, surgery, pathology, and follow-up were analyzed. Results: Among the 16 patients, 15 were female and 1 was male, with a median age of 14 years (range: 7-16). Abdominal pain was the most frequent presenting symptom (n=12) and other presentations included jaundice, abdominal swelling, or amenorrhea, while 2 patients reported no symptoms. The pancreatic head was the most common tumor site (n=9), and the median tumor size was 5 cm (range: 1-14 cm). Surgical procedures included enucleation (n=10), distal pancreatectomy (n=3), and the Whipple procedure (n=3). Despite positive surgical margins in 9 patients, only 2 experienced local recurrence. No patients received adjuvant therapy. Postoperative complications occurred in 2 cases. One patient developed papillary thyroid carcinoma during follow-up. The median follow-up duration was 50 months (range: 2-108), and all patients were alive and all but one are disease-free at the last evaluation. Conclusion: Pediatric pancreatic SPN predominantly affects adolescent girls and often presents incidentally. Surgical resection yields excellent long-term outcomes even in the presence of positive margins. Continued follow-up is essential due to potential recurrence and rare secondary malignancies.
- 4 March 2026
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (3) , 246-253
Clinical Characteristics and Treatment Outcomes of Pediatric Pancreatic Solid Pseudopapillary Tumors: A Single-Center Experience
Objective: This study aimed to evaluate clinical characteristics, surgical management approaches, and long-term outcomes of pediatric patients with histopathologically-confirmed pancreatic solid pseudopapillary neoplasm (SPN) at a single tertiary center over 10 years. Methods: A retrospective review was conducted of 16 pediatric patients with pancreatic SPN who were treated at the hospital between 2015 and 2025. Data on demographics, clinical presentation, imaging, surgery, pathology, and follow-up were analyzed. Results: Among the 16 patients, 15 were female and 1 was male, with a median age of 14 years (range: 7-16). Abdominal pain was the most frequent presenting symptom (n=12) and other presentations included jaundice, abdominal swelling, or amenorrhea, while 2 patients reported no symptoms. The pancreatic head was the most common tumor site (n=9), and the median tumor size was 5 cm (range: 1-14 cm). Surgical procedures included enucleation (n=10), distal pancreatectomy (n=3), and the Whipple procedure (n=3). Despite positive surgical margins in 9 patients, only 2 experienced local recurrence. No patients received adjuvant therapy. Postoperative complications occurred in 2 cases. One patient developed papillary thyroid carcinoma during follow-up. The median follow-up duration was 50 months (range: 2-108), and all patients were alive and all but one are disease-free at the last evaluation. Conclusion: Pediatric pancreatic SPN predominantly affects adolescent girls and often presents incidentally. Surgical resection yields excellent long-term outcomes even in the presence of positive margins. Continued follow-up is essential due to potential recurrence and rare secondary malignancies.
- 19 February 2026
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 29 (3) , 210-216
The Association of Fetal Cyanotic Versus Non-Cyanotic Cardiac Malformations and Placental Vascular Malperfusion
Objective: Placental abnormalities are frequently observed in congenital heart disease (CHD) pregnancies, yet detailed histopathological evaluations are limited. This study investigated placental vascular lesions in CHD cases, with comparisons between cyanotic and non-cyanotic subtypes. Methods: Term singleton pregnancies with prenatally diagnosed moderate-to-severe CHD were compared to gestational age-matched controls. Placentas were assessed using standardized histopathological criteria, and CHD cases were stratified based on cyanosis. Results: Among 60 placentas analyzed (40 CHD and 20 control), fetal vascular malperfusion (FVM) was significantly more frequent in the CHD group ( P = .003). Other lesions, including maternal vascular malperfusion and inflammation-related findings, showed no statistically significant differences. In subgroup analysis, no clear differences emerged between cyanotic and non-cyanotic groups. Conclusion: CHD is strongly associated with placental FVM, indicating a possible fetal circulatory disturbance. While histological patterns were similar across CHD subtypes, the presence of FVM may provide important insights for neonatal risk assessment and management.
- 19 February 2026
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 29 (3) , 210-216
The Association of Fetal Cyanotic Versus Non-Cyanotic Cardiac Malformations and Placental Vascular Malperfusion
Objective: Placental abnormalities are frequently observed in congenital heart disease (CHD) pregnancies, yet detailed histopathological evaluations are limited. This study investigated placental vascular lesions in CHD cases, with comparisons between cyanotic and non-cyanotic subtypes. Methods: Term singleton pregnancies with prenatally diagnosed moderate-to-severe CHD were compared to gestational age-matched controls. Placentas were assessed using standardized histopathological criteria, and CHD cases were stratified based on cyanosis. Results: Among 60 placentas analyzed (40 CHD and 20 control), fetal vascular malperfusion (FVM) was significantly more frequent in the CHD group ( P = .003). Other lesions, including maternal vascular malperfusion and inflammation-related findings, showed no statistically significant differences. In subgroup analysis, no clear differences emerged between cyanotic and non-cyanotic groups. Conclusion: CHD is strongly associated with placental FVM, indicating a possible fetal circulatory disturbance. While histological patterns were similar across CHD subtypes, the presence of FVM may provide important insights for neonatal risk assessment and management.
- Open Access
- 30 May 2022
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 16 (3) , 210-214
Akut Kısa Süreli Selenyum Tedavisi: Akut Böbrek Hasarında Kurtarıcı Bir Tedavi Olabilir mi?
Amaç: İskemi/Reperfüzyon (İR) hasarı nativ ve nakil böbrekte akut böbrek hasarının önemli bir nedenidir. Bu durum oksitadif bir ortam oluşturarak doku hasarına neden olur. Bu çalışmanın amacı kısa süreli akut selenyum (Se) tedavisinin oksidatif durum ve akut böbrek hasarına etkilerini değerlendirmektir. Gereç ve Yöntemler: Bu çalışmada 18 yetişkin Long Evans cinsi rat rastgele 3 gruba ayrıldı. Genel anestezi altında steril koşullarda batın insize edildi, bilateral böbrek damar yapıları ayrıldı. Sol renal arter klemplendi, sağ nefrektomi yapıldı, 45 dakika iskemi uygulanmasını takiben sol renal arter klempi açıldı ve 4 saat reperfüzyon uygulandı. İR ve Se tedavisi grubuna, cerrahi işlemden 4 saat önce ve reperfüzyon periyodunun bitiminden 4 saat sonra 0.625 mg/kg Se oral verildi. İR grubuna benzer protokol ile 1 cc steril salin oral uygulandı. Sham grubu dışında tüm ratlar ikinci ilaç uygulamasından 4 saat sonra sakrifiye edildi. Kan ve doku örnekleri alınarak histopatolojik değerlendirme ve kan kreatinin, total thiol, nativ thiol, disülfid düzey ve dinamik thiol/disülfid oran ölçümleri yapıldı. Bulgular: Selenyum tedavisi alan grupta İR hasarı öncesi ve sonrası thiol düzeylerinde anlamlı azalma görülmezken İR grubunda thiol düzeyinde anlamlı düşme gözlendi (p=0.345, p=0.028). Selenyum tedavisi alan ve almayan gruplar böbrek fonksiyonları ve histopatolojik açıdan karşılaştırıldığında Se tedavisi alan ratlarda anlamlı iyileşme saptanmadı (p=0.053). Sonuç: Kısa süreli akut Se tedavisi hücrenin oksidatif durumunu düzeltmekle birlikte bu durum histopatolojik ve biyokimyasal iyileşme için yetersizdir. Ayrıca halihazırda hasarlı böbrekte Se tedavisinin mevcut durumu kötüleştirdiği düşünülmektedir.
- 30 May 2022
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 16 (3) , 210-214
Open AccessAkut Kısa Süreli Selenyum Tedavisi: Akut Böbrek Hasarında Kurtarıcı Bir Tedavi Olabilir mi?
Amaç: İskemi/Reperfüzyon (İR) hasarı nativ ve nakil böbrekte akut böbrek hasarının önemli bir nedenidir. Bu durum oksitadif bir ortam oluşturarak doku hasarına neden olur. Bu çalışmanın amacı kısa süreli akut selenyum (Se) tedavisinin oksidatif durum ve akut böbrek hasarına etkilerini değerlendirmektir. Gereç ve Yöntemler: Bu çalışmada 18 yetişkin Long Evans cinsi rat rastgele 3 gruba ayrıldı. Genel anestezi altında steril koşullarda batın insize edildi, bilateral böbrek damar yapıları ayrıldı. Sol renal arter klemplendi, sağ nefrektomi yapıldı, 45 dakika iskemi uygulanmasını takiben sol renal arter klempi açıldı ve 4 saat reperfüzyon uygulandı. İR ve Se tedavisi grubuna, cerrahi işlemden 4 saat önce ve reperfüzyon periyodunun bitiminden 4 saat sonra 0.625 mg/kg Se oral verildi. İR grubuna benzer protokol ile 1 cc steril salin oral uygulandı. Sham grubu dışında tüm ratlar ikinci ilaç uygulamasından 4 saat sonra sakrifiye edildi. Kan ve doku örnekleri alınarak histopatolojik değerlendirme ve kan kreatinin, total thiol, nativ thiol, disülfid düzey ve dinamik thiol/disülfid oran ölçümleri yapıldı. Bulgular: Selenyum tedavisi alan grupta İR hasarı öncesi ve sonrası thiol düzeylerinde anlamlı azalma görülmezken İR grubunda thiol düzeyinde anlamlı düşme gözlendi (p=0.345, p=0.028). Selenyum tedavisi alan ve almayan gruplar böbrek fonksiyonları ve histopatolojik açıdan karşılaştırıldığında Se tedavisi alan ratlarda anlamlı iyileşme saptanmadı (p=0.053). Sonuç: Kısa süreli akut Se tedavisi hücrenin oksidatif durumunu düzeltmekle birlikte bu durum histopatolojik ve biyokimyasal iyileşme için yetersizdir. Ayrıca halihazırda hasarlı böbrekte Se tedavisinin mevcut durumu kötüleştirdiği düşünülmektedir.
- Open Access
- 29 September 2020
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 14 (5) , 385-390
KOLESTAZLI ÇOCUKLARDA KLİNİK VE LABORATUAR BULGULARININ YAŞ GRUPLARINA GÖRE DEĞERLENDİRİLMESİ
Objective: Cholestasis in childhood results from different etiologies according to age groups. The differences between clinical and laboratory findings in patients with cholestasis during the first 3 months of age and after 3 months are unknown. The aim of this study is to investigate the clinical, laboratory; and histopathological findings of patients with cholestasis according to age groups. Material and Methods: Between January 2013-March 2017, files of the patients diagnosed as cholestasis in 0-18 year of age were retrospectively reviewed. Demographic data, complaints, physical examination, laboratory, ultrasonography and if liver biopsy is done histopathologic findings of the patients were recorded. Results: Forty-four patients (29 M, 65%) were diagnosed as cholestasis during the study period. Twenty-five (56%) of the patients were younger than 3 months (Group 1), 19 (44%) of the patients were older than 3 months (Group 2). The patients were diagnosed as cholestasis in the first 3 months were idiopathic neonatal hepatitis (n=5, 20%), non-syndromic paucity of intrahepatic bile ducts (n=5, 20%), biliary atresia (n=3, 12%), progressive familial intrahepatic cholestasis (n=3, 12%), cholestasis owing to prematurity/ sepsis/ parenteral nutrition (n=3, 12%) respectively. Aetiology of the cholestasis after 3 months were cryptogenic hepatitis (n=5, 26.3%) and autoimmune hepatitis (n=4, 21%) respectively. Mean duration of follow up was 17.7±15.1 months. Total and direct bilirubin levels were higher in Group 1 patients (p=0.017 and p= 0.023 respectively) whereas albumin levels were lower (p=0.051). Ultrasonographic evaluation revealed statistically homogenic liver parenchyma in Group 1 (p=0.000). Liver histopathologic examination showed fibrosis in Group 2 (p=0.000). Conclusion: Cholestasis in childhood occurs different reasons. Although bilirubin levels were higher in young children, chronic changes such as liver fibrosis are common in older children.
- 29 September 2020
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 14 (5) , 385-390
Open AccessKOLESTAZLI ÇOCUKLARDA KLİNİK VE LABORATUAR BULGULARININ YAŞ GRUPLARINA GÖRE DEĞERLENDİRİLMESİ
Objective: Cholestasis in childhood results from different etiologies according to age groups. The differences between clinical and laboratory findings in patients with cholestasis during the first 3 months of age and after 3 months are unknown. The aim of this study is to investigate the clinical, laboratory; and histopathological findings of patients with cholestasis according to age groups. Material and Methods: Between January 2013-March 2017, files of the patients diagnosed as cholestasis in 0-18 year of age were retrospectively reviewed. Demographic data, complaints, physical examination, laboratory, ultrasonography and if liver biopsy is done histopathologic findings of the patients were recorded. Results: Forty-four patients (29 M, 65%) were diagnosed as cholestasis during the study period. Twenty-five (56%) of the patients were younger than 3 months (Group 1), 19 (44%) of the patients were older than 3 months (Group 2). The patients were diagnosed as cholestasis in the first 3 months were idiopathic neonatal hepatitis (n=5, 20%), non-syndromic paucity of intrahepatic bile ducts (n=5, 20%), biliary atresia (n=3, 12%), progressive familial intrahepatic cholestasis (n=3, 12%), cholestasis owing to prematurity/ sepsis/ parenteral nutrition (n=3, 12%) respectively. Aetiology of the cholestasis after 3 months were cryptogenic hepatitis (n=5, 26.3%) and autoimmune hepatitis (n=4, 21%) respectively. Mean duration of follow up was 17.7±15.1 months. Total and direct bilirubin levels were higher in Group 1 patients (p=0.017 and p= 0.023 respectively) whereas albumin levels were lower (p=0.051). Ultrasonographic evaluation revealed statistically homogenic liver parenchyma in Group 1 (p=0.000). Liver histopathologic examination showed fibrosis in Group 2 (p=0.000). Conclusion: Cholestasis in childhood occurs different reasons. Although bilirubin levels were higher in young children, chronic changes such as liver fibrosis are common in older children.